N.sup.2 -substituted-L-arginine derivatives and the pharmaceutically
申请人:Mitsubishi Chemical Industries Ltd.
公开号:US04069323A1
公开(公告)日:1978-01-17
N.sup.2 -substituted-L-arginine esters and amides, and the pharmaceutically acceptable acid addition salts thereof have been found to be effective as pharmaceutical agents for the inhibition and suppression of thrombosis.
N.sup.2-取代-L-精氨酸酯和酰胺,以及其药用酸盐被发现对抑制和抑制血栓形成具有有效作用。
HtrA Inhibitors and CagA Inhibitors and Use Thereof
申请人:PSOMAGEN INC.
公开号:US20220122691A1
公开(公告)日:2022-04-21
The present application relates to new HtrA inhibitors and use thereof. Additionally, the present application also relates to new peptides for inhibiting CagA and use thereof.
US4069323A
申请人:——
公开号:US4069323A
公开(公告)日:1978-01-17
US4133880A
申请人:——
公开号:US4133880A
公开(公告)日:1979-01-09
Kuznetsova; Rudenskaya; Bogacheva, Russian Journal of Bioorganic Chemistry, 1997, vol. 23, # 11, p. 773 - 780